AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug
AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug ASTRAZENECA-NEURIMMUNE/ (URGENT, PIX)AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug https://ift.tt/U1DKPmz
No comments:
Post a Comment